# Boundless Bio, Inc. (BOLD)

> Source: Nexqual · https://nexqual.com/BOLD · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Boundless Bio, Inc. (BOLD), nexqual.com/BOLD" · informational, not investment advice.

**Price:** USD 2.35 (-1.67% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.39 · day 2.34–2.53 · 52w 0.96–3.16 · market cap $54.3M · NMS

## Key facts
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 4 (range 4–4).
- Total return with dividends: 1Y +66.7% vs S&P 500 +18.1%; 5Y -83.5% vs S&P 500 +85.1%.

## Analysts
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 4 (low 4, high 4).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-03-25) |
|---|---|---|
| Total return | +66.7% | -83.5% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +67.0% | -50.6% |
| Volatility (annualized) | 78.9% | 83.8% |
| Max drawdown | -30.5% (Oct 2025→Feb 2026) | -92.9% (Mar 2024→Jun 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/BOLD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt